Home

Jun18_Cover-Hero_1366x768.jpg

A Small Molecule Renaissance? Teaching an Old Modality New Tricks

Career Success

jun18-career-success

Crucial Conversations: A Look Outward

In Part 3 of the Crucial Conversations series, we learn about listening, vulnerability, and perspective.

Read More

Student Member Spotlight

June18-studentspotlight

Embracing Opportunity

Ph.D. candidate Ashley Lay looks forward to a career in drug development and formulation.

Read More

Pharmaceutical Science Update

Posted By Linda Brown
Found In Microsite: AAPS News Magazine
June 13, 2018 The Food and Drug Administration (FDA) is ready to start rolling out its plans on how to better give patients a voice in the development and approval of new drugs. The agency will issue a draft guidance document explaining possible ways ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
June 13, 2018 Drug industry leaders now have a clearer path to meet with the Food and Drug Administration (FDA) to discuss how to speed up the approval process for cheaper copies of complex biologic drugs (83 Fed. Reg. 26,060). Those drugs “often represent ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
June 13, 2018 A new strategy by the world’s largest medical research agency for collecting and using data could accelerate solutions to pressing health challenges. On June 4, the National Institutes of Health (NIH) published its first-ever strategic ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
June 13, 2018 Canada has generally been slow to approve biosimilar products, but its thumbs-up for Apobiologix’s biosimilar of bone marrow stimulant Neulasta (pegfilgrastim) beat regulators in the U.S. and other major markets to the punch. Health Canada ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
June 5, 2018 A possible step by the Food and Drug Administration (FDA) to address safety concerns in a new experimental drug law could limit drug companies wanting to fast-track unrelated and potentially groundbreaking medicines. On May 30, President ...